Brief: Formycon and Zydus Partner For Exclusive Licensing And Supply Agreement Of FYB206
Dec 9 (Reuters) - Formycon AG FYB.DE: FORMYCON AND ZYDUS PARTNER FOR EXCLUSIVE LICENSING AND SUPPLY AGREEMENT OF FYB206, A BIOSIMILARTO KEYTRUDA®(PEMBROLIZUMAB),IN U.S. AND CANADA AGREEMENT INCLUDES MID-TEENS-MILLION-EURO UPFRONT PAYMENTS FYB206 CLINICAL DEVELOPMENT NEARLY COMPLETED, DATA EXPECTED Q1 2026 Source text: ID:nEQ5PsG4Ya Further company coverage: FYB.DE (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka